SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-009050
Filing Date
2018-04-25
Accepted
2018-04-25 16:16:47
Documents
40
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20180331.htm 10-Q 590649
2 EX-31.1 mnov-ex311_8.htm EX-31.1 10998
3 EX-31.2 mnov-ex312_9.htm EX-31.2 10903
4 EX-32.1 mnov-ex321_6.htm EX-32.1 7875
5 EX-32.2 mnov-ex322_7.htm EX-32.2 7804
  Complete submission text file 0001564590-18-009050.txt   2041028

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20180331.xml EX-101.INS 257046
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20180331.xsd EX-101.SCH 22987
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20180331_cal.xml EX-101.CAL 23357
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20180331_def.xml EX-101.DEF 61208
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20180331_lab.xml EX-101.LAB 189975
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20180331_pre.xml EX-101.PRE 136267
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 18774548
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences